Johnson & Johnson 4Q Revenues: $13.7 billion (+8.5%) 4Q Earnings: $2.2 billion (+3.5%) FY Revenues: $53.3 billion (+5.6%) FY Earnings: $11 billion (+10%) Comments: Worldwide pharmaceutical sales were $23.3 billion for the year, up 4%. In the quarter, both domestic and international sales increased 4%. For the year, domestic sales were up 6% and international sales were up 11%. Sales growth reflects the strong performance of Risperdal, Remicade, Topamax, Velcade and Concer...